TriSalus Life Sciences, Inc.
Oncology tech firm enhancing drug delivery and immunotherapy for solid liver & pancreas tumors.
TLSI | NDAQ
Overview
Corporate Details
- ISIN(s):
- US58507N2045 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 6272 WEST 91ST AVENUE, 80031 WESTMINSTER
- Website:
- https://trisaluslifesci.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company dedicated to developing treatments for patients with solid tumors, particularly in the liver and pancreas. The company's therapeutic platform integrates its proprietary Pressure-Enabled Drug Delivery™ (PEDD™) technology with investigational immunotherapies. This approach aims to overcome critical barriers to treatment efficacy, such as high intratumoral pressure and immunosuppressive tumor microenvironments, thereby enhancing the delivery and effectiveness of cancer therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all TriSalus Life Sciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TriSalus Life Sciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TriSalus Life Sciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
